Compare VVOS & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | TSE |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7M | 19.9M |
| IPO Year | 2020 | 2014 |
| Metric | VVOS | TSE |
|---|---|---|
| Price | $1.82 | $0.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $6.25 | $1.00 |
| AVG Volume (30 Days) | 149.2K | ★ 1.2M |
| Earning Date | 11-19-2025 | 02-13-2026 |
| Dividend Yield | N/A | ★ 4.00% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $17,317,000.00 | ★ $3,133,800,000.00 |
| Revenue This Year | $28.86 | N/A |
| Revenue Next Year | $48.70 | $4.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.76 | N/A |
| 52 Week Low | $1.67 | $0.43 |
| 52 Week High | $7.95 | $5.99 |
| Indicator | VVOS | TSE |
|---|---|---|
| Relative Strength Index (RSI) | 37.92 | 38.56 |
| Support Level | $1.67 | $0.43 |
| Resistance Level | $1.83 | $0.95 |
| Average True Range (ATR) | 0.16 | 0.08 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 16.39 | 5.79 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.